Acute Myeloid Leukemia

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Acute Myeloid Leukemia
Nov 20, 2024, 14:44 | Insight
Talha Badar: What we have learned about TP53-mutated AML?
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared an article by Moazzam Shahzad on X:…
Nov 10, 2024, 16:55 | Blog
A Teen’s Story of Hope and Support from The Leukemia and Lymphoma Society
The Leukemia & Lymphoma Society posted the following on X: “'Fast forward two years, I…
Nov 8, 2024, 14:30 | Insight
Keith W Pratz: The utility of post remission use of GCSF in the VIALE-A trial
Keith W Pratz, Director of Leukemia, Hospital of University of Pennsylvania Philadelphia, shared his recent…
Nov 5, 2024, 00:26 | Blog
Impact of post-remission G-CSF in AML treatment
Mostafa Faisal, Adjunct Assistant Professor at Alfaisal University, shared a paper by Courtney D. DiNardo…
Nov 2, 2024, 17:34 | Insight
Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…
Oct 26, 2024, 17:36 | Insight
Anand Patel: Prevention and Treatment of Transformation of MPNs to AML
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…
Oct 12, 2024, 15:43 | Insight
Sanam Loghavi: 81195 is the newly assigned AMA CPTcode 4 Optical Genome Mapping
Sanam Loghavi shared a post on X about a recent paper published in the American…
Oct 5, 2024, 11:39 | Insight
Talha Badar: Transplant or no transplant for TP53 mutated AML
Talha Badar shared a post on X about a recent paper titled "Transplant or no…
Oct 1, 2024, 17:45 | Insight
Talha Badar: Different aspects of TP53 mutated AML
Talha Badar shared a post on X: "I will share our collaborative effort in looking at…
Sep 28, 2024, 16:29 | Blog
Thor Halfdanarson: A good review for those encountering patients with t-MN
Thor Halfdanarson, Vice President at North American Neuroendocrine Tumor Society, shared the following insights about a…
Sep 10, 2024, 00:28 | Blog
Chloe’s leukemia battle: ‘My knees just gave way’ - Children’s Cancer Institute
Children’s Cancer Institute shared the following on LinkedIn: “Chloe was a happy 9-year-old who loved…
Aug 29, 2024, 20:11 | Career
Alique Topalian received the Inspirational Award from the Armenian Bone Marrow Donor Registry
Alique Topalian shared a post by University of Cincinnati Cancer Center, on LinkedIn adding: “So…
Aug 28, 2024, 15:53 | Career
Alique Topalian: I received the Inspirational Award from the Armenian Bone Marrow Donor Registry
Alique Topalian shared on LinkedIn: "This weekend I received one of the greatest honors of…
Aug 24, 2024, 10:51 | Insight
Shahrin Ahmed: High health care utilization and poor survival rate in older adults with AML
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Older…
Aug 17, 2024, 07:45 | Insight
Razan Mohty: Outcomes of patients with IDH1 or 2 mutated AML after alloHCT
Razan Mohty, Assistant Professor at UAB Medicine, shared a post on X about a recent…
Aug 10, 2024, 01:18 | Blog
JAMA Oncology Review: The Latest Treatment Options for Acute Myeloid Leukemia by Sylvester Comprehensive Cancer Center
Recently approved drugs are rapidly changing the treatment of patients with acute myeloid leukemia (AML),…
Aug 9, 2024, 09:44 | Blog
Talha Badar: AML, MDS, and CML highlights from EHA24
Talha Badar posted on LinkedIn: "Acute myeloid leukemia AML MDS highlights from recently conducted European Hematology…
Aug 4, 2024, 07:01 | Insight
Rama Al Hamed: Allogeneic SCT in de novo core-binding factor AML in first complete remission
Rama Al Hamed, Hematology/Oncology Fellow at Herbert Irving Comprehensive Cancer Centre, shared on X: "Allogeneic…
Aug 4, 2024, 06:30 | Insight
Lisa Bouchier-Hayes: Caspase-2 in nucleophosmin-mutated acute myeloid leukemia
Lisa Bouchier-Hayes, Associate Professor at Baylor College of Medicine, shared on X: "So excited to…
Aug 1, 2024, 02:29 | Blog
Early Intervention Key to Managing Shwachman-Diamond Syndrome: Insights from Dana-Farber's Molecular Tumor Board
Dana-Farber Cancer Institute shared a post on LinkedIn: "Imagine trying to navigate a paper map…
Jul 21, 2024, 17:12 | Insight
2024 Visionaries of the Year National Winners - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: "Meet the incredible 2024 Visionaries…
Jul 19, 2024, 13:27 | Insight
Fadi Haddad: Hyperleukocytosis in Acute myeloid leukemia
Fadi Haddad, Assistant Professor at Leukemia Department at MD Anderson Cancer Center, shared a post…
Jul 19, 2024, 13:19 | Insight
Sanam Loghavi: Optical genome mapping in acute myeloid leukemia
Sanam Loghavi, shared a post on X about a recent paper titled "Optical genome mapping improves…
Jul 15, 2024, 13:21 | Blog
Talha Badar: CRh as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia
Talha Badar shared on X: "Complete remission with partial hematological recovery as a palliative endpoint for…
Jul 11, 2024, 02:39 | Blog
Mathijs Sanders: Grateful for receiving the LSBR Fellowship!
Mathijs Sanders, Researcher, Erasmus MC Cancer Institute, shared on X: "Extremely grateful for receiving the LSBR…
Jul 7, 2024, 16:11 | Insight
Amer Zeidan: Excellent paper by Abdulrahman Alhajahjeh under mentorship of Maximilian Stahl
Amer Zeidan shared a post on X: "Another excellent paper by University of Jordan super…
Jul 4, 2024, 10:46 | Positive
Dr. Eytan Stein to lead a novel clinical trial for AML patients
Memorial Sloan Kettering Cancer Center shared on X: "A new class of drugs known as…
Jun 29, 2024, 16:57 | Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 19, 2024, 23:22 | Blog
Amer Zeidan: Looking forward to finding cures for all AML and MDS patients
Amer Zeidan shared on X: "Looking forward to finding cures for all Acute Myeloid Leukemia…
Jun 18, 2024, 23:17 | Insight
Talha Badar: TP53 mutation in Myeloproliferative neoplasms
Talha Badar shared on X:      , "Genomic landscape, impact allelic burden, time to…
Jun 18, 2024, 14:51 | Insight
Amer Zeidan: Our newest paper on 61 TP53-mutated AML
Amer Zeidan shared on X: "Our newest paper with a detailed Integrated analysis of genetic,…
Jun 13, 2024, 09:00 | Insight
Key Advances in Targeted Radiotherapies at SNMMI24 by Actinium
Actinium Pharmaceuticals presented compelling data from their diverse clinical trials at SNMMI24: Key among these…
Jun 2, 2024, 22:16 | Insight
ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Clinical trial results suggest new treatment options could reduce need for stem cell transplants and…
May 30, 2024, 09:41 | Blog
Sarita Jaiswal: What could be a greater gift than what we got today on Cancer Day from a little girl
Sarita Jaiswal, Program Director and consultant at Dharamshila Narayana superspecility hospital, shared on their LinkedIn:…
May 30, 2024, 02:01 | Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 24, 2024, 10:50 | Cancer Types
Acute Myeloid Leukemia: What patients should know about
What is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a severe and aggressive form…
May 13, 2024, 13:11 | Insight
Justin Kaner: To transplant or not to transplant….. 
Justin Kaner, Assistant Professor  of the Leukemia Program at Weill Cornell, shared on X: "To…
May 12, 2024, 07:00 | Blog
Ellen Madarang: We proved that treatment of 80-90 year olds with AML can be done
Ellen Madarang, Hematology Oncology Clinical Pharmacist  at Sylvester Comprehensive Cancer Center, shared the following post…
May 12, 2024, 06:02 | Insight
Rasoul Pourebrahim: Our latest publication on studying mutant p53-driven Acute Myeloid Leukemia
Rasoul Pourebrahim, Assistant Professor at MD Anderson, made the following post on LinkedIn: "Our paper…
May 12, 2024, 01:40 | Insight
Justin Watts: A significant portion of patients at the extremes of older age (80-90) still derive benefit from the VEN-HMA regimen
Justin Watts et al. report that standard of care treatment for acute myeloid leukemia extends…
May 1, 2024, 21:39 | Blog
It’s the one-two punch cancer treatment that ‘floats like a butterfly, and STINGs like a bee’! - WEHI (Walter and Eliza Hall Institute of Medical Research)
WEHI (Walter and Eliza Hall Institute of Medical Research) made the foll0wing post on LinkedIn:…
Apr 27, 2024, 14:29 | Opinion
Amer Zeidan: I find MRD literature increasingly confusing as it pertains to decision making
Amer Zeidan shared a post on X: "I have to say I find MRD literature…
Apr 26, 2024, 18:12 | Insight
Invariant natural killer T cells response to acute myeloid leukemia and pancreatic cancer liver metastasis - Easy IMMUNO-ATMPs
Easy IMMUNO-ATMPs shared on LinkedIn: “Invariant natural killer T cells response to acute myeloid leukemia…
Apr 21, 2024, 06:16 | Dialogues
Oncodaily Dialogues #8 Mikkael Sekeres/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Apr 12, 2024, 11:59 | Insight
Wei Zhang: Congratulations to an outstanding physician scientist Tim Pardee for the new R21 grant that addresses health disparities in acute myeloid leukemia
Wei Zhang, Director at Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer…
Mar 23, 2024, 04:57 | Insight
Alicia Perzolli: Happy to share my first publication for my Ph.D. at Princess Máxima Center for Pediatric Oncology about 'Targeting the innate immune system in pediatric and adult AML'
Mar 11, 2024, 03:24 | Career
Amer Zeidan was appointed as the inaugural Chief of the Division of Hematologic Malignancies at Yale Cancer Center
Yale Cancer Center shared on LinkedIn: "We are pleased to announce that Amer Zeidan was…
Mar 10, 2024, 20:49 | Insight
Hagop Kantarjian: In this phase 2 study, a convenient, fully-oral regimen was effective and safe in an older/unfit population with acute myeloid leukemia
  Hagop Kantarjian, a Professor and Chair of the Department of Leukemia at The University…
Dec 7, 2023, 04:32 | Insight
Yuki Nishida: This is one of the continuous efforts to overcome therapy resistance in acute myeloid leukemia by enhancing the activity of p53
Yuki Nishida, Instructor at MD Anderson Cancer Center, recently shared on LinkedIn: "Our paper has…
Oct 7, 2023, 19:19 | Insight
Johanna Olweus: Excited to share our work, which shows that T cells targeting a shared neoantigen eliminate acute myeloid leukemia, including cancer stem cells, in vivo, in a disease-relevant model.
Oct 1, 2023, 04:00 | Blog
Maite Gorostegui: The one most adaptable to change is the one that survives...
Quoting Maite Gorostegui, Pediatric Oncologist at the Pediatric Cancer Center Barcelona, on LinkedIn: “The One…
All: 51 Posts: 1 - 100
Special Coverage